Literature DB >> 33666167

Narcolepsy type 1 features across the life span: age impact on clinical and polysomnographic phenotype.

Althea Lividini1, Fabio Pizza2,3, Marco Filardi2, Stefano Vandi2,3, Francesca Ingravallo1, Elena Antelmi4, Oliviero Bruni5, Filomena Irene Ilaria Cosentino6, Raffaele Ferri6, Biancamaria Guarnieri7, Sara Marelli8, Luigi Ferini-Strambi8, Andrea Romigi9, Enrica Bonanni10, Michelangelo Maestri10, Michele Terzaghi11,12, Raffaele Manni11, Giuseppe Plazzi3,13.   

Abstract

STUDY
OBJECTIVES: Narcolepsy type 1 (NT1) is a chronic neurological disorder typically arising during adolescence and young adulthood. Recent studies demonstrated that NT1 presents with age-specific features, especially in children. With this study we aimed to describe and to compare the clinical pictures of NT1 in different age groups.
METHODS: In this cross-sectional, multicenter study, 106 untreated patients with NT1 enrolled at the time of diagnosis underwent clinical evaluation, a semistructured interview (including the Epworth Sleepiness Scale), nocturnal video-polysomnography, and the Multiple Sleep Latency Test. Patients were enrolled in order to establish 5 age-balanced groups (childhood, adolescence, adulthood, middle age, and senior).
RESULTS: The Epworth Sleepiness Scale score showed a significant increase with age, while self-reported diurnal total sleep time was lower in older and young adults, with the latter also complaining of automatic behaviors in more than 90% of patients. Children reported the cataplexy attacks to be more frequent (> 1/d in 95% of patients). "Recalling an emotional event," "meeting someone unexpectedly," "stress," and "anger" were more frequently reported in adult and older adult patients as possible triggers of cataplexy. Neurophysiological data showed a higher number of sleep-onset rapid eye movement periods on the Multiple Sleep Latency Test in adolescent compared to senior patients and an age-progressive decline in sleep efficiency.
CONCLUSIONS: Daytime sleepiness, cataplexy features and triggers, and nocturnal sleep structure showed age-related difference in patients with NT1; this variability may contribute to diagnostic delay and misdiagnosis.
© 2021 American Academy of Sleep Medicine.

Entities:  

Keywords:  cataplexy; emotional triggers; narcolepsy type 1; nocturnal sleep; sleepiness

Mesh:

Year:  2021        PMID: 33666167      PMCID: PMC8314618          DOI: 10.5664/jcsm.9198

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.324


  50 in total

1.  Validation of a cataplexy questionnaire in 983 sleep-disorders patients.

Authors:  S Anic-Labat; C Guilleminault; H C Kraemer; J Meehan; J Arrigoni; E Mignot
Journal:  Sleep       Date:  1999-02-01       Impact factor: 5.849

2.  Hypocretin (orexin) deficiency in human narcolepsy.

Authors:  S Nishino; B Ripley; S Overeem; G J Lammers; E Mignot
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

Review 3.  From state dissociation to status dissociatus.

Authors:  Elena Antelmi; Raffaele Ferri; Alex Iranzo; Isabelle Arnulf; Yves Dauvilliers; Kailash P Bhatia; Rocco Liguori; Carlos H Schenck; Giuseppe Plazzi
Journal:  Sleep Med Rev       Date:  2015-08-06       Impact factor: 11.609

4.  Daytime sleep state misperception in a tertiary sleep centre population.

Authors:  M S Schinkelshoek; K de Wit; V Bruggink; R Fronczek; G J Lammers
Journal:  Sleep Med       Date:  2020-01-10       Impact factor: 3.492

5.  Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.

Authors:  Adi Aran; Mali Einen; Ling Lin; Guiseppe Plazzi; Seiji Nishino; Emmanuel Mignot
Journal:  Sleep       Date:  2010-11       Impact factor: 5.849

6.  Sleep-disordered breathing and periodic limb movements in narcolepsy with cataplexy: a systematic analysis of 35 consecutive patients.

Authors:  Fabio Pizza; Sonja Tartarotti; Rositsa Poryazova; Christian R Baumann; Claudio L Bassetti
Journal:  Eur Neurol       Date:  2013-05-08       Impact factor: 1.710

7.  Does age at the onset of narcolepsy influence the course and severity of the disease?

Authors:  Sona Nevsimalova; Jitka Buskova; David Kemlink; Karel Sonka; Jelena Skibova
Journal:  Sleep Med       Date:  2009-05-06       Impact factor: 3.492

Review 8.  Narcolepsy in the older adult: epidemiology, diagnosis and management.

Authors:  Sangeeta S Chakravorty; David B Rye
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Prevalence of narcolepsy symptomatology and diagnosis in the European general population.

Authors:  M M Ohayon; R G Priest; J Zulley; S Smirne; T Paiva
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

10.  Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.

Authors:  Markku Partinen; Outi Saarenpää-Heikkilä; Ismo Ilveskoski; Christer Hublin; Miika Linna; Päivi Olsén; Pekka Nokelainen; Reija Alén; Tiina Wallden; Merimaaria Espo; Harri Rusanen; Jan Olme; Heli Sätilä; Harri Arikka; Pekka Kaipainen; Ilkka Julkunen; Turkka Kirjavainen
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

View more
  2 in total

1.  Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis.

Authors:  Zhongxing Zhang; Yves Dauvilliers; Giuseppe Plazzi; Geert Mayer; Gert Jan Lammers; Joan Santamaria; Markku Partinen; Sebastiaan Overeem; Rafael Del Rio Villegas; Karel Sonka; Rosa Peraita-Adrados; Raphaël Heinzer; Aleksandra Wierzbicka; Birgit Högl; Mauro Manconi; Eva Feketeova; Antonio Martins da Silva; Jitka Bušková; Claudio L A Bassetti; Lucie Barateau; Fabio Pizza; Elena Antelmi; Jari K Gool; Rolf Fronczek; Carles Gaig; Ramin Khatami
Journal:  Nat Sci Sleep       Date:  2022-05-31

2.  Systematic Review: Sleep Disorders Based on Objective Data in Children and Adolescents Treated for a Brain Tumor.

Authors:  Anne Sophie Lind Helligsoe; Kathrine Synne Weile; Line Kenborg; Louise Tram Henriksen; Yasmin Lassen-Ramshad; Ali Amidi; Lisa Maria Wu; Jeanette Falck Winther; Line Pickering; René Mathiasen
Journal:  Front Neurosci       Date:  2022-02-22       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.